Another study reported that, besides reduction of intracellular drug accumulation, constitutive activation of PI3K/Akt signals and dysfunction of the tumor suppressor gene p53 might contribute to cisplatin-resistance of cancer cells, which were regulated by PTEN gene [23, 31, 32]. The gene discussed is AKT1; the disease is cancer.